Skip to main content

Advertisement

Log in

A Dual Inhibitor of Cyclooxygenase and 5-Lipoxygenase Protects Against Kainic Acid-Induced Brain Injury

  • Original Paper
  • Published:
NeuroMolecular Medicine Aims and scope Submit manuscript

Abstract

Systemic administration of kainic acid causes inflammation and apoptosis in the brain, resulting in neuronal loss. Dual cyclooxygenase/5-lipoxygenase (COX/5-LOX) inhibitors could represent a possible neuroprotective approach in preventing glutamate excitotoxicity. Consequently, we investigated the effects of a dual inhibitor of COX/5-LOX following intraperitoneal administration of kainic acid (KA, 10 mg/kg) in rats. Animals were randomized to receive either the dual inhibitor of COX/5-LOX (flavocoxid, 20 mg/kg i.p.) or its vehicle (1 ml/kg i.p.) 30 min after KA administration. Sham brain injury rats were used as controls. We evaluated protein expression of phosphorylated extracellular signal-regulated kinase (p-ERK1/2) and tumor necrosis factor alpha (TNF-α) as well as levels of malondialdehyde (MDA), prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) in the hippocampus. Animals were also observed for monitoring behavioral changes according to Racine Scale. Finally, histological analysis and brain edema evaluation were carried out. Treatment with the dual inhibitor of COX/5-LOX decreased protein expression of p-ERK1/2 and TNF-α in hippocampus, markedly reduced MDA, LTB4 and PGE2 hippocampal levels, and also ameliorated brain edema. Histological analysis showed a reduction in cell damage in rats treated with the dual inhibitor of COX/5-LOX, particularly in hippocampal subregion CA3c. Moreover, flavocoxid significantly improved behavioral signs following kainic acid administration. Our results suggest that dual inhibition of COX/5-LOX by flavocoxid has neuroprotective effects during kainic acid-induced excitotoxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Altavilla, D., Minutoli, L., Polito, F., Irrera, N., Arena, S., Magno, C., et al. (2012). Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia. British Journal Pharmacology, 167, 95–108.

    Article  CAS  Google Scholar 

  • Altavilla, D., Squadrito, F., Bitto, A., Polito, F., Burnett, B. P., Di Stefano, V., et al. (2009). Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages. British Journal Pharmacology, 157, 1410–1418.

    Article  CAS  Google Scholar 

  • Baik, E. J., Kim, E. J., Lee, S. H., & Moon, C. (1999). Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Research, 843, 118–129.

    Article  CAS  PubMed  Google Scholar 

  • Ben-Ari, Y. (1985). Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy. Neuroscience, 14, 375–403.

    Article  CAS  PubMed  Google Scholar 

  • Bishnoi, M., Patil, C. S., Kumar, A., & Kulkarni, S. K. (2007). Co-administration of acetyl-11-keto-beta-boswellic acid, a specific 5-lipoxygenase inhibitor, potentiates the protective effect of COX-2 inhibitors in kainic acid-induced neurotoxicity in mice. Pharmacology, 79, 34–41.

    Article  CAS  PubMed  Google Scholar 

  • Bitto, A., Minutoli, L., David, A., Irrera, N., Rinaldi, M., et al. (2012). Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis. Critical Care, 16, R32.

    Article  PubMed Central  PubMed  Google Scholar 

  • Burnett, B. P., Bitto, A., Altavilla, D., Squadrito, F., Levy, R. M., & Pillai, L. (2011). Flavocoxid inhibits phospholipase A2, peroxidase moieties of the cyclooxygenases (COX), and 5-lipoxygenase, modifies COX-2 gene expression, and acts as an antioxidant. Mediators of Inflammation, 2011, 385780.

    Article  PubMed Central  PubMed  Google Scholar 

  • Burnett, B. P., Jia, Q., Zhao, Y., & Levy, R. M. (2007a). A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation. Journal of Medicinal Food, 10, 442–451.

    Article  CAS  PubMed  Google Scholar 

  • Burnett, B. P., & Levy, R. M. (2012). Flavocoxid (Limbrel®) manages osteoarthritis through modification of multiple inflammatory pathways: A review. Functional Foods in Health and Disease, 2, 379–413.

    CAS  Google Scholar 

  • Burnett, B. P., Silva, S., Mesches, M. H., Wilson, S., & Jia, Q. (2007b). Safety evaluation of a combination, defined extract of Scutellaria baicalensis and Acacia catechu. Journal of Food Biochemistry, 31, 797–825.

    Article  CAS  Google Scholar 

  • Calapai, G., Squadrito, F., Rizzo, A., Marciano, M. C., Campo, G. M., & Caputi, A. P. (1995). Multiple actions of the coumarine derivative cloricromene and its protective effects on ischemic brain injury. Naunyn-Schmiedeberg’s archives of pharmacology, 351, 209–215.

    Article  CAS  PubMed  Google Scholar 

  • Chen, B. C., Chang, Y. S., Kang, J. C., Hsu, M. J., Sheu, J. R., Chen, T. L., et al. (2004). Peptidoglycan induces nuclear factor-kappaB activation and cyclooxygenase-2 expression via Ras, Raf-1, and ERK in RAW 264.7 macrophages. The Journal of biological chemistry, 279, 20889–20897.

    Article  CAS  PubMed  Google Scholar 

  • Chou, T. C., Chang, L. P., Li, C. Y., Wong, C. S., & Yang, S. P. (2003). The antiinflammatory and analgesic effects of baicalin in carrageenan evoked thermal hyperalgesia. Anesthesia & Analgesia Journal, 97, 1724–1729.

    Article  CAS  Google Scholar 

  • Chu, J., & Praticò, D. (2009). The 5-lipoxygenase as a common pathway for pathological brain and vascular aging. Cardiovascular Psychiatry and Neurology, 2009, 174657.

    Article  PubMed Central  PubMed  Google Scholar 

  • De Clerq, E. (2005). Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Medicinal Research Reviews, 20, 323–349.

    Article  Google Scholar 

  • Farooqui, A. A. (2011). Neurochemical aspects of inflammation in brain. In A. A. Farooqui & T. Farooqui (Eds.), Molecular aspects of neurodegeneration and neuroprotection. Bentham Science.

  • Farooqui, A. A., Ong, W. Y., & Horrocks, L. A. (2006). Inhibitors of brain phospholipase A2 activity: Their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacological Reviews, 58, 591–620.

    Article  CAS  PubMed  Google Scholar 

  • Gobbo, O. L., & O’Mara, S. M. (2004). Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration. Neuroscience, 125, 317–327.

    Article  CAS  PubMed  Google Scholar 

  • Holtman, L., van Vliet, E. A., van Schaik, R., Queiroz, C. M., Aronica, E., & Gorter, J. A. (2009). Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy. Epilepsy Research, 84, 56–66.

    Article  CAS  PubMed  Google Scholar 

  • Huang, Y., Tsang, S. Y., Tao, X., & Chen, Z. Y. (2005). Biological properties of baicalein in cardiovascular system. Current Drug Targets - Cardiovascular & Hematological Disorders, 5, 177–184.

    Article  CAS  Google Scholar 

  • Jeong, E. A., Jeon, B. T., Shin, H. J., Kim, N., Lee, D. H., Kim, H. J., et al. (2011). Ketogenic diet-induced peroxisome proliferator-activated receptor-γ activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced seizures. Experimental Neurology, 232, 195–202.

    Article  CAS  PubMed  Google Scholar 

  • Jung, K. H., Chu, K., Lee, S. T., Kim, J., Sinn, D. I., Kim, J. M., et al. (2006). Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiology of Disease, 23, 237–246.

    Article  CAS  PubMed  Google Scholar 

  • Kawaguchi, K., Hickey, R. W., Rose, M. E., Zhu, L., Chen, J., & Graham, S. H. (2005). Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus. Brain Research, 1050, 130–137.

    Article  CAS  PubMed  Google Scholar 

  • Kumar, A., Prakash, A., Pahwa, D., & Mishra, J. (2012). Montelukast potentiates the protective effect of rofecoxib against kainic acid-induced cognitive dysfunction in rats. Pharmacology, Biochemistry and Behavior, 103, 43–52.

    Article  CAS  PubMed  Google Scholar 

  • Kunz, T., & Oliw, E. H. (2001). The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus. European Journal of Neuroscience, 13, 569–575.

    Article  CAS  PubMed  Google Scholar 

  • Leone, S., Ottani, A., & Bertolini, A. (2007). Dual acting anti-inflammatory drugs. Current Topics in Medicinal Chemistry, 7, 265–275.

    Article  CAS  PubMed  Google Scholar 

  • Levy, R. M., Khokhlov, A., Kopenkin, S., Bart, B., Ermolova, T., Kantemirova, R., et al. (2010). Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: A randomized multicenter controlled trial in subjects with osteoarthritis of the knee. Advances in Therapy, 27, 731–742.

    Article  CAS  PubMed  Google Scholar 

  • Lubin, F. D., Johnston, L. D., Sweatt, J. D., & Anderson, A. E. (2005). Kainate mediates nuclear factor-kappa B activation in hippocampus via phosphatidylinositol-3 kinase and extracellular signal-regulated protein kinase. Neuroscience, 133, 969–981.

    Article  CAS  PubMed  Google Scholar 

  • Manev, H., Uz, T., & Qu, T. (2000). 5-Lipoxygenase and cyclooxygenase mRNA expression in rat hippocampus: Early response to glutamate receptor activation by kainate. Experimental Gerontology, 35, 1201–1209.

    Article  CAS  PubMed  Google Scholar 

  • Marini, H., Altavilla, D., Bellomo, M., Adamo, E. B., Marini, R., Laureanti, F., et al. (2004a). Modulation of IL-1 beta gene expression by lipid peroxidation inhibition after kainic acid-induced rat brain injury. Experimental Neurology, 188, 178–186.

    Article  CAS  PubMed  Google Scholar 

  • Marini, H., Costa, C., Passaniti, M., Esposito, M., Campo, G. M., Ientile, R., et al. (2004b). Levetiracetam protects against kainic acid-induced toxicity. Life Sciences, 74, 1253–1264.

    Article  CAS  PubMed  Google Scholar 

  • Mehta, A., Prabhakar, M., Kumar, P., Deshmukh, R., & Sharma, P. L. (2013). Excitotoxicity: Bridge to various triggers in neurodegenerative disorders. European Journal of Pharmacology, 698, 6–18.

    Article  CAS  PubMed  Google Scholar 

  • Messina, S., Bitto, A., Aguennouz, M., Mazzeo, A., Migliorato, A., Polito, F., et al. (2009). Flavocoxid counteracts muscle necrosis and improves functional properties in MDX mice: A comparison study with methylprednisolone. Experimental Neurology, 220, 349–358.

    Article  CAS  PubMed  Google Scholar 

  • Paxinos, G., & Watson, C. (1986). The rat brain in stereotaxic coordinates. Sydney: Academic Press.

    Google Scholar 

  • Polito, F., Bitto, A., Irrera, N., Squadrito, F., Fazzari, C., Minutoli, L., et al. (2010). Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis. British Journal of Pharmacology, 161, 1002–1011.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Racine, R. J. (1972). Modification of seizure activity by electrical stimulation: Motor seizure. EEG. Clinical Neurophysiology, 32, 281–294.

    Article  CAS  Google Scholar 

  • Rojas, A., & Dingledine, R. (2013). Ionotropic glutamate receptors: Regulation by G-protein-coupled receptors. Molecular Pharmacology, 83, 746–752.

    Article  CAS  PubMed  Google Scholar 

  • Singh, D. P., & Chopra, K. (2014). Flavocoxid, dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, exhibits neuroprotection in rat model of ischaemic stroke. Pharmacology, Biochemistry and Behavior, 120, 33–42.

    Article  CAS  PubMed  Google Scholar 

  • Takemiya, T., Maehara, M., Matsumura, K., Yasuda, S., Sugiura, H., & Yamagata, K. (2006). Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region. Neuroscience Research, 56, 103–110.

    Article  CAS  PubMed  Google Scholar 

  • Takemiya, T., Matsumura, K., & Yamagata, K. (2007). Roles of prostaglandin synthesis in excitotoxic brain diseases. Neurochemistry International, 51, 112–120.

    Article  CAS  PubMed  Google Scholar 

  • Takemiya, T., & Yamagata, K. (2013). Intercellular signaling pathway among endothelia, astrocytes and neurons in excitatory neuronal damage. International Journal of Molecular Sciences, 14, 8345–8357.

    Article  PubMed Central  PubMed  Google Scholar 

  • Van Loon, I. M. (1997). The golden root: Clinical applications of Scutellaria baicalensis GEORGI flavonoids as modulators of the inflammatory response. Alternative Medicine Review, 2, 472–480.

    Google Scholar 

  • Vincent, P., & Mulle, C. (2009). Kainate receptors in epilepsy and excitotoxicity. Neuroscience, 158, 309–323.

    Article  CAS  PubMed  Google Scholar 

  • Wang, Y., Liu, P. P., Li, L. Y., Zhang, H. M., & Li, T. (2011). Hypothermia reduces brain edema, spontaneous recurrent seizure attack, and learning memory deficits in the kainic acid treated rats. CNS Neuroscience & Therapeutics, 17, 271–280.

    Article  CAS  Google Scholar 

  • Wang, Q., Yu, S., Simonyi, A., Sun, G. Y., & Sun, A. Y. (2005). Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Molecular Neurobiology, 31, 3–16.

    Article  CAS  PubMed  Google Scholar 

  • Zhang, X. M., & Zhu, J. (2011). Kainic Acid-induced neurotoxicity: Targeting glial responses and glia-derived cytokines. Current Neuropharmacology, 9, 388–398.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zheng, X. Y., Zhang, H. L., Luo, Q., & Zhu, J. (2011). Kainic acid-induced neurodegenerative model: Potentials and limitations. Journal of Biomedicine and Biotechnology, 2011, 457079.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This study was granted by a departmental funding.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All applicable international, national and/or institutional guidelines for the care and use of animals were followed.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesco Squadrito.

Additional information

Letteria Minutoli and Herbert Marini have equally contributed to this paper.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Minutoli, L., Marini, H., Rinaldi, M. et al. A Dual Inhibitor of Cyclooxygenase and 5-Lipoxygenase Protects Against Kainic Acid-Induced Brain Injury. Neuromol Med 17, 192–201 (2015). https://doi.org/10.1007/s12017-015-8351-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12017-015-8351-0

Keywords

Navigation